Patents by Inventor Hiroyuki Yoneyama

Hiroyuki Yoneyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160326403
    Abstract: A composite sheet 1 for forming a protective film which includes: a pressure sensitive adhesive sheet 2 obtained by laminating a pressure sensitive adhesive layer 22 on one surface of a base material 21; a protective film-forming film 3 laminated on the pressure sensitive adhesive layer 22 side of the pressure sensitive adhesive sheet 2; and a pressure sensitive adhesive layer 4 for jigs, the layer being laminated on a peripheral portion on the opposite side of the pressure sensitive adhesive sheet 2 side of the protective film-forming film 3, wherein a thickness of the pressure sensitive adhesive layer 22 of the pressure sensitive adhesive sheet 2 is from 1 to 8 ?m. According to the composite sheet 1 for forming a protective film, it is possible to effectively suppress loosening of the sheet 1 in the heating step and the cooling step, and the dicing and picking up processes can also be performed satisfactorily.
    Type: Application
    Filed: December 25, 2014
    Publication date: November 10, 2016
    Inventors: Hiroyuki Yoneyama, Naoya Saiki, Akio Kabuto
  • Publication number: 20160272839
    Abstract: A composition for protective film formation capable of forming a protective film excellent in attachability by a tape mounter or the like, with good visibility at a laser-printed portion and heat dissipation properties, allowing a protective film-equipped chip having high reliability to be manufactured, and a sheet for protective film formation and a protective film-equipped chip are provided. The composition for protective film formation contains a polymer component (A), a curable component (B), and a heat conductive filler (C) having an average particle size of 2.0 to 10.0 ?m. The content of components that are liquid at 25° C. contained in the composition for protective film formation is 20 to 70 parts by mass relative to 100 parts by mass of the total of the (A) component and the (B) component. The content of the (C) component is 40 to 65 volume % relative to the total amount of the composition for protective film formation.
    Type: Application
    Filed: November 10, 2014
    Publication date: September 22, 2016
    Applicant: LINTEC CORPORATION
    Inventors: Daisuke YAMAMOTO, Hiroyuki YONEYAMA
  • Patent number: 9389339
    Abstract: The method for producing an antireflection film is provided. The method includes, a step of coating a coating composition including the following components (A) to (D) on a base material to form a coating film, a step of volatilizing the solvent from the coating film for drying the coating film, and a step of curing the coating film to form a cured layer, in which a multilayer structure having different refractive indices from the coating composition is formed: (A) a fluorine-containing polymer with a specific structure, having a polyalkylene oxide group in the molecule, (B) non-surface-modified inorganic fine particles, or inorganic fine particles that are surface-treated with a silane coupling agent having a molecular weight of 600 or less, (C) a curable binder having no fluorine atom in the molecule, and (D) a solvent, provided that the mass ratio of [component (A)+component (B)]/[component (C)] is from 1/199 to 60/40.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: July 12, 2016
    Assignee: FUJIFILM CORPORATION
    Inventors: Nobuyuki Akutagawa, Hiroyuki Yoneyama, Daiki Wakizaka
  • Publication number: 20160187540
    Abstract: The method for producing an antireflection film is provided. The method includes, a step of coating a coating composition including the following components (A) to (D) on a base material to form a coating film, a step of volatilizing the solvent from the coating film for drying the coating film, and a step of curing the coating film to form a cured layer, in which a multilayer structure having different refractive indices from the coating composition is formed: (A) a fluorine-containing polymer with a specific structure, having a polyalkylene oxide group in the molecule, (B) non-surface-modified inorganic fine particles, or inorganic fine particles that are surface-treated with a silane coupling agent having a molecular weight of 600 or less, (C) a curable binder having no fluorine atom in the molecule, and (D) a solvent, provided that the mass ratio of [component (A)+component (B)]/[component (C)] is from 1/199 to 60/40.
    Type: Application
    Filed: April 19, 2012
    Publication date: June 30, 2016
    Applicant: FUJIFILM Corporation
    Inventors: Nobuyuki AKUTAGAWA, Hiroyuki YONEYAMA, Daiki WAKIZAKA
  • Publication number: 20160185089
    Abstract: A composite sheet (1) for forming a protective film which is provided with an adhesive sheet (2) formed by laminating an adhesive layer (22) on one surface of a base material (21), and a protective-film forming film (3) laminated on the adhesive layer (22) side of the adhesive sheet (2), wherein the adhesive sheet (2) does not have a through hole penetrating the adhesive sheet (2) in the thickness direction, and the light transmittance at a wavelength of 532 nm of the adhesive sheet (2), measured using an integrating sphere, is from 25 to 85%.
    Type: Application
    Filed: July 16, 2014
    Publication date: June 30, 2016
    Applicant: Lintec Corporation
    Inventors: Hiroyuki Yoneyama, Naoya Saiki
  • Publication number: 20160176169
    Abstract: A composite sheet (1) for forming a protective film, including an adhesive sheet (2) formed by laminating an adhesive layer (22) on one surface of a base material (21), and a protective-film forming film (3) laminated on the adhesive layer (22) side of the adhesive sheet (2), wherein the adhesive sheet (2) does not have a through hole penetrating through the adhesive sheet (2) in the thickness direction, and the light transmittance of the adhesive sheet (2) at a wavelength of 532 nm which is measured using an integrating sphere is from 75 to 85%. According to this composite sheet (1) for forming a protective film, while using an adhesive sheet having no through holes, it is still possible to suppress the generation of a gas reservoir between the adhesive sheet and the protective-film forming film (protective film) when laser printing is performed on the protective-film forming film (protective film).
    Type: Application
    Filed: July 16, 2014
    Publication date: June 23, 2016
    Inventors: Hiroyuki Yoneyama, Naoya Saiki
  • Publication number: 20160091758
    Abstract: The backlight unit includes two or more light sources, and a wavelength conversion member positioned on each of optical paths of light emitted by the two or more light sources, wherein the wavelength conversion member includes a wavelength conversion layer containing at least a phosphor emitting green light when excited with exciting light and a phosphor emitting red light when excited with exciting light, and at least either maximum emission wavelengths or angles of incidence of entry into the wavelength conversion member of the light emitted by the two or more light sources differ.
    Type: Application
    Filed: September 29, 2015
    Publication date: March 31, 2016
    Applicant: FUJIFILM CORPORATION
    Inventor: Hiroyuki YONEYAMA
  • Publication number: 20160046840
    Abstract: A protective film-forming composite sheet 10 comprises a pressure sensitive adhesive sheet 16 in which a pressure sensitive adhesive layer 12 is provided on a base material 11, a protective film-forming film 13, and a release film 14. When ? (mN/25 mm) represents the maximum peel force between the protective film-forming film 13 and the release film 14; ? (mN/25 mm) represents the minimum peel force between the pressure sensitive adhesive sheet 16 and the protective film-forming film 13; and ? (mN/25 mm) represents the maximum peel force between the pressure sensitive adhesive sheet 16 and the protective film-forming film 13, the following relationships (1) to (3) hold for ?, ?, and ?; ??70??(1) ?/??0.50??(2) ??2000??(3).
    Type: Application
    Filed: March 26, 2014
    Publication date: February 18, 2016
    Applicant: LINTEC CORPORATION
    Inventors: Hiroyuki YONEYAMA, Naoya SAIKI
  • Publication number: 20150345618
    Abstract: A controller is configured to determine a current gear ratio step determined on the basis of gear ratio calculation Rg to be actual gear ratio of revolution Nm of main shaft 3a and revolution Nc of counter shaft 3b as well as gear ratio map for defining gear ratio variable allowance range for each of gear ratio steps. When making a decision of status of the determined current gear ratio step, the controller is configured to make delay timer get started when the gear ratio calculation Rg goes within the gear ratio variable allowance range of next step and halt to make a decision of the current gear ratio step while the delay timer is activated. The controller is also configured to make a decision of the status of the current gear ratio step after a predetermined delayed time Tn*(n=1,2, . . . ) is elapsed.
    Type: Application
    Filed: May 7, 2015
    Publication date: December 3, 2015
    Inventors: Toru IWASAKI, Mitsuhiro NAKAMURA, Hiroyuki YONEYAMA, Akira NAKAMURA
  • Publication number: 20150337313
    Abstract: From experiments using colitis model mice, the present inventors discovered that siRNAs that suppress the CHST15 gene expression have a therapeutic effect against Crohn's disease or ulcerative colitis. Specifically, the present inventors discovered that the siRNAs which suppress the CHST15 gene expression can serve as an agent for promoting mucosal healing, in particular, an agent for treating Crohn's disease or ulcerative colitis, and thereby completed the present invention.
    Type: Application
    Filed: July 17, 2012
    Publication date: November 26, 2015
    Applicant: STELIC INSTITUTE & CO.
    Inventors: Hiroyuki YONEYAMA, Masato FUJII
  • Publication number: 20150330602
    Abstract: A wavelength conversion member including a wavelength conversion layer comprising a quantum dot, wherein the wavelength conversion layer includes an organic matrix, and the organic matrix contains a polymer and one or more of compounds selected from the group consisting of compounds represented by general formula (1) and the like; and a quantum dot-containing polymerizable composition containing a quantum dot, a radical polymerizable compound, and one or more of compounds selected from the group consisting of compounds represented by general formula (1) and the like are provided. The wavelength conversion member has an excellent light resistance and the composition has an excellent photocurability which enables a production of a wavelength conversion member containing a quantum dot which has a less tendency to lower its light emission intensity.
    Type: Application
    Filed: May 15, 2015
    Publication date: November 19, 2015
    Applicant: FUJIFILM Corporation
    Inventors: Takashi YONEMOTO, Hiroyuki YONEYAMA, Tatsuya OBA, Makoto KAMO, Yutaka ADEGAWA
  • Patent number: 9176258
    Abstract: An optical laminate includes a support and an antistatic layer formed from a composition containing the following (A) to (C) and having an average thickness of from 0.03 to 0.40 ?m: (A) a hydrophobilized conductive polymer composition containing a ?-conjugated system conductive polymer and an anion group-containing polymer dopant; (B) an inorganic particle having an average particle size of from 1 to 300 nm; and (C) an ionizing radiation curable compound.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: November 3, 2015
    Assignee: FUJIFILM CORPORATION
    Inventors: Naoya Nishimura, Hiroyuki Yoneyama
  • Publication number: 20150290238
    Abstract: As a result of dedicated studies, the present inventors succeeded in discovering, for the first time, that fibrogenesis could be suppressed at the physiological tissue level by inhibiting sulfation at position 4 or 6 of GalNAc, which is a sugar that constitutes sugar chains. Furthermore, the present inventors conducted studies using various disease model animals, and as a result, successfully demonstrated that inhibitors of sulfation at position 4 or 6 of GalNAc had therapeutic effects on diseases caused by tissue fibrogenesis (tissue fibrogenic disorders).
    Type: Application
    Filed: May 5, 2015
    Publication date: October 15, 2015
    Applicant: Stelic Institute of Regenerative Medicine, Stelic Institute & Co.
    Inventors: Hiroyuki YONEYAMA, Jun KOYAMA, Masato FUJII
  • Patent number: 9050774
    Abstract: A laminate having: a support; and an antistatic layer, wherein the antistatic layer is provided on the support and is made with a composition comprising at least (A) an electrically conductive polymer, and (B) a binder component, the antistatic layer has regions having local concentration of the electrically conductive polymer (A) of 1.5 times or more higher than the average value of the concentration of the electrically conductive polymer (A) in the antistatic layer and the regions are in contact with each other to form a three-dimensional connection structure in the antistatic layer, and a common logarithmic value of the surface resistivity of which unit is ?/sq of the antistatic layer is 3.0 or more and 13.0 or less.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: June 9, 2015
    Assignee: FUJIFILM CORPORATION
    Inventors: Masaaki Suzuki, Hiroyuki Yoneyama, Katsuyuki Takada
  • Patent number: 8920889
    Abstract: An optical film having: a hard coat layer; an optically anisotropic layer; and a transparent support, wherein the optically anisotropic layer contains a liquid crystalline compound and a binder, the hard coat layer, the transparent support, and the optically anisotropic layer are laminated in this order, a surface of the optically anisotropic layer contains a fluorine-containing compound not forming covalent bond with the binder of the optically anisotropic layer, a surface of the optical film on the hard coat layer-formed side contains a fluorine-containing or silicone series compound being fixed by covalent bond, and a topmost surface properties of the optical film on hard coat layer-formed side satisfies the specific conditions.
    Type: Grant
    Filed: April 11, 2013
    Date of Patent: December 30, 2014
    Assignee: FUJIFILM Corporation
    Inventors: Hiroyuki Yoneyama, Yuta Takahashi
  • Patent number: 8896802
    Abstract: A surface light source unit includes, in the following order: a light source; a light collecting sheet having light collection portions on at least one side of the light collecting sheet; and a light transmissive substrate having a flat portion and recesses on at least one side of the light transmissive substrate.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: November 25, 2014
    Assignee: Fujifilm Corporation
    Inventors: Hiroyuki Yoneyama, Yasuyuki Sasada, Yujiro Yanai
  • Patent number: 8889236
    Abstract: An optical film having: a hard coat layer; an optically anisotropic layer; and a transparent support, wherein the optically anisotropic layer contains a liquid crystalline compound and a binder, the hard coat layer, the transparent support, and the optically anisotropic layer are laminated in this order, a surface of the optically anisotropic layer contains a fluorine-containing compound not forming covalent bond with the binder of the optically anisotropic layer, a surface of the optical film on the hard coat layer-formed side contains a fluorine-containing or silicone series compound being fixed by covalent bond, and a topmost surface properties of the optical film on hard coat layer-formed side satisfies the specific conditions.
    Type: Grant
    Filed: April 11, 2013
    Date of Patent: November 18, 2014
    Assignee: FUJIFILM Corporation
    Inventors: Hiroyuki Yoneyama, Yuta Takahashi
  • Publication number: 20140178306
    Abstract: Fatty liver was induced by administering agents for inducing organ inflammation to experimental animals to evoke insulin resistance and by rearing them with high-fat diets. As a result, steatohepatitis was successfully induced in the animals. The animals show pathological findings similar to those of humans. By using these model animals, substances for treating or preventing diseases can be efficiently screened and the efficacy of medicinal substances can be effectively evaluated.
    Type: Application
    Filed: February 27, 2014
    Publication date: June 26, 2014
    Applicant: STELIC INSTITUTE OF REGENERATIVE MEDICINE, STELIC INSTITUTE & CO.
    Inventors: HIROYUKI YONEYAMA, MASATO FUJII
  • Publication number: 20140135379
    Abstract: The present invention provides methods for retaining and expressing physiologically active substances in a target tissue-specific-manner, by administering the physiologically active substances to target submucous tissue. Specifically, the present inventors demonstrated that, when physiologically active substances were directly administered into submucous tissues without using a carrier, the physiologically active substances were effectively and safely retained at the administration sites over long periods without loss and diffusion, and produced the effect acting in a reservoir-like fashion. The physiologically active substances administered as described above were demonstrated to produce the therapeutic effect without having an influence on organs other than the administered organ.
    Type: Application
    Filed: January 17, 2014
    Publication date: May 15, 2014
    Applicants: NIIGATA UNIVERSITY, Stelic Institute of Regenerative Medicine, Stelic Institute & CO.
    Inventors: Hiroyuki YONEYAMA, Kenji SUZUKI
  • Publication number: 20140128452
    Abstract: As a result of dedicated studies, the present inventors succeeded in discovering, for the first time, that fibrogenesis could be suppressed at the physiological tissue level by inhibiting sulfation at position 4 or 6 of GalNAc, which is a sugar that constitutes sugar chains. Furthermore, the present inventors conducted studies using various disease model animals, and as a result, successfully demonstrated that inhibitors of sulfation at position 4 or 6 of GalNAc had therapeutic effects on diseases caused by tissue fibrogenesis (tissue fibrogenic disorders).
    Type: Application
    Filed: November 8, 2013
    Publication date: May 8, 2014
    Applicant: STELIC INSTITUTE OF REGENERATIVE MEDICINE, STELIC INSTITUTE & CO.
    Inventors: Hiroyuki YONEYAMA, Jun KOYAMA, Masato FUJII